RVTY

Revvity Inc

Add to Watchlist

Advanced Chart

103.670

+1.7(1.667%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

104.410

Open

102.450

VWAP

103.53

Vol

2.00M

Mkt Cap

12.22B

Low

101.570

Amount

207.01M

EV/EBITDA(TTM)

17.51

Total Shares

123.39M

14.25B

EV/OCF(TTM)

21.96

P/S(TTM)

4.57

Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

764.79M

+4.83%

1.508

+6.22%

712.27M

+4.09%

1.269

-0.85%

711.33M

+2.81%

1.138

-6.69%

Estimates Revision

The market is revising Upward the revenue expectations for Revvity, Inc. (RVTY) for FY2025, with the revenue forecasts being adjusted by 0.73% over the past three months. During the same period, the stock price has changed by 9.06%.

Revenue Estimates for FY2025

Revise Upward

+0.73%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-0.18%

In Past 3 Month

Stock Price

Go Up

+9.06%

In Past 3 Month

14 Analyst Rating

12.58% Upside

Wall Street analysts forecast RVTY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RVTY is 116.71 USD with a low forecast of 100.00 USD and a high forecast of 135.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

9 Buy

5 Hold

0 Sell

Moderate Buy

12.58% Upside

Current: 103.670

Low

100.00

Averages

116.71

High

135.00

12.58% Upside

Current: 103.670

Low

100.00

Averages

116.71

High

135.00

BofA

Buy

downgrade

$116 -> $110

2025-06-26

Reason

BofA

Price Target

$116 -> $110

2025-06-26

downgrade

Buy

Reason

BofA lowered the firm's price target on Revvity to $110 from $116 and keeps a Buy rating on the shares. The firm is updating its price targets for stocks under its coverage in the Life Sciences & Diagnostic Tools, LSTs, sector, the analyst tells investors. The firm notes LSTs remain under pressure as uncertainty persists with the macro environment and U.S. government policies. Recent weeks, however, have seen some signs of improvement as tariff concerns have cools slightly, the firm adds.

Citi

Patrick Donnelly

Buy

maintain

$135

2025-05-22

Reason

Citi

Patrick Donnelly

Price Target

$135

2025-05-22

maintain

Buy

Reason

Baird

Catherine Ramsey

Buy

Maintains

$141 → $127

2025-04-21

Reason

Baird

Catherine Ramsey

Price Target

$141 → $127

2025-04-21

Maintains

Buy

Reason

Baird lowered the firm's price target on Revvity to $127 from $141 and keeps an Outperform rating on the shares. The firm upated its model ahead of its Q1 results.

Wells Fargo

Brandon Couillard

Hold

Maintains

$130 → $102

2025-04-17

Reason

Wells Fargo

Brandon Couillard

Price Target

$130 → $102

2025-04-17

Maintains

Hold

Reason

Barclays

Luke Sergott

Buy

Maintains

$140 → $110

2025-04-10

Reason

Barclays

Luke Sergott

Price Target

$140 → $110

2025-04-10

Maintains

Buy

Reason

Barclays lowered the firm's price target on Revvity to $110 from $140 and keeps an Overweight rating on the shares as part of a Q1 earnings preview for life science tools and diagnostics group. Tools are still defensive, but less so than in the past given the threat of the pharma-specific tariffs potentially causing another round of budget cuts, the analyst tells investors in a research note. Barclays also downgraded the contract research organizations on lower visibility.

Keybanc

Paul Knight

Buy

Maintains

$132 → $145

2025-02-03

Reason

Keybanc

Paul Knight

Price Target

$132 → $145

2025-02-03

Maintains

Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Revvity Inc (RVTY.N) is 20.36, compared to its 5-year average forward P/E of 21.91. For a more detailed relative valuation and DCF analysis to assess Revvity Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

21.91

Current PE

20.36

Overvalued PE

25.77

Undervalued PE

18.05

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

17.53

Current EV/EBITDA

15.82

Overvalued EV/EBITDA

20.69

Undervalued EV/EBITDA

14.37

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

4.57

Current PS

4.16

Overvalued PS

5.29

Undervalued PS

3.85

Financials

Annual

Quarterly

FY2025Q1

YoY :

+2.28%

664.76M

Total Revenue

FY2025Q1

YoY :

-4.36%

77.21M

Operating Profit

FY2025Q1

YoY :

+45.21%

41.67M

Net Income after Tax

FY2025Q1

YoY :

+66.67%

0.35

EPS - Diluted

FY2025Q1

YoY :

-10.72%

118.12M

Free Cash Flow

FY2025Q1

YoY :

+3.40%

56.49

Gross Profit Margin - %

FY2025Q1

YoY :

+98.54%

20.37

FCF Margin - %

FY2025Q1

YoY :

+41.86%

6.27

Net Margin - %

FY2025Q1

YoY :

+60.49%

3.29

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

55.3K

USD

3-6

Months

235.4K

USD

6-9

Months

4.7M

USD

0-12

Months

789.1K

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

154.3K

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

1.5M

Volume

Months

6-9

1.7M

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

73.0K

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

24.0K

USD

Months

3-6

16.0K

USD

Months

6-9

8.0K

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

55.3K

USD

3-6

Months

235.4K

USD

6-9

Months

4.7M

USD

0-12

Months

789.1K

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

RVTY News & Events

Events Timeline

2025-06-02 (ET)

2025-06-02

08:11:18

Revvity announces launch of three Mimix reference standards for IVD use

2025-04-28 (ET)

2025-04-28

06:04:06

Revvity backs 2025 adjusted EPS view $4.90-$5.00, consensus $4.94

2025-04-28

06:02:19

Revvity reports Q1 adjusted EPS $1.01, consensus 95c

News

3.0

07-27SeekingAlpha

Here are the major earnings before the open Monday

3.0

07-25NASDAQ.COM

Pre-Market Earnings Report for July 28, 2025 : EPD, RVTY, FMX, RITM, ARLP, NGD, BOH, BFST, ALRS, BMRC, BWFG, PROV

8.0

07-16NASDAQ.COM

YieldBoost Revvity To 8.9% Using Options

People Also Watch

Plains All American Pipeline LP

East West Bancorp Inc

Sprouts Farmers Market Inc

Summit Therapeutics Inc

FAQ

What is Revvity Inc (RVTY) stock price today?

The current price of RVTY is 103.67 USD — it has increased 1.67 % in the last trading day.

RVTY

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

RVTY News & Events

Events Timeline

News

People Also Watch

FAQ

What is Revvity Inc (RVTY) stock price today?

What is Revvity Inc (RVTY)'s business?

What is the price predicton of RVTY Stock?

What is Revvity Inc (RVTY)'s revenue for the last quarter?

What is Revvity Inc (RVTY)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Revvity Inc (RVTY)'s fundamentals?

How many employees does Revvity Inc (RVTY). have?

What is Revvity Inc (RVTY) market cap?